Holly Kidd
Internal Medicine · Ruston, LANPI 1376513788
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $584 and has fallen 96.8% since, to $19 in 2025.
Across 128 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$410
- Novo Nordisk$333
- Amgen$237
- Bayer$210
- Boehringer Ingelheim$145
- Pfizer$137
- plus $612 from 19 others
What the payments were for
- Food & beverage$2,06399%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $410 |
| Novo Nordisk | 22 | $333 |
| Amgen | 14 | $237 |
| Bayer | 12 | $210 |
| Boehringer Ingelheim | 10 | $145 |
| Pfizer | 8 | $137 |
| Kowa Pharmaceuticals America, Inc. | 7 | $128 |
| GSK | 5 | $75 |
| Merck | 5 | $64 |
| Nevro Corp. | 3 | $56 |
| Abbott | 2 | $37 |
| AstraZeneca | 2 | $28 |
| Global Blood Therapeutics, Inc. | 1 | $25 |
| Organogenesis Inc. | 1 | $24 |
| Novartis | 1 | $20 |
| Inogen, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| AbbVie | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
How this compares
$2,082 in reported general payments places this provider in the 75th percentile of 1,528 internal medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 26 | $1,677 |
| Memantine Hcl | 23 | $516 |
| Gabapentin | 24 | $381 |
| Atorvastatin Calcium | 31 | $295 |
| Levothyroxine Sodium | 21 | $251 |
| Losartan Potassium | 32 | $244 |
| Omeprazole | 27 | $162 |
| Rosuvastatin Calcium | 20 | $141 |
| Paroxetine Hcl | 19 | $125 |
| Amlodipine Besylate | 25 | $120 |
| Phenytoin Sodium Extended | 12 | $117 |
| Carvedilol | 13 | $111 |
| Lovastatin | 20 | $102 |
| Lisinopril | 27 | $94 |
| Metformin Hcl | 20 | $94 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Ruston
- Donna RyanBaton Rouge$991K
- Steven DeitelzweigNew Orleans$939K
- Bruce SamuelsCovington$200K
- Amanda FontenotMarrero$142K
- John SchwabBaton Rouge$122K
- Daniel EnglertNew Orleans$74K
- Everett BrownGretna$71K
- Rajan KhannaShreveport$54K
- Samuel StaggEunice$54K
- Bryan LebeanLafayette$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.